Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Johnson and Johnson
Colorcon
Covington
US Department of Justice
Queensland Health
Accenture
AstraZeneca

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010210

« Back to Dashboard

NDA 010210 describes METIMYD, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the METIMYD profile page.

The generic ingredient in METIMYD is prednisolone acetate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for 010210
Tradename:METIMYD
Applicant:Schering
Ingredient:prednisolone acetate; sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.5%;10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;OPHTHALMICStrength0.5%;10%
Approval Date:Sep 9, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chubb
AstraZeneca
Argus Health
Fuji
Cerilliant
Citi
Daiichi Sankyo
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.